Pfizer Debt Securities (Trading and AFS) - Accumulated Gross Unrealized Loss decreased by 94.3% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.4%, from $36.00M to $2.00M. Over 5 years (FY 2020 to FY 2025), Debt Securities (Trading and AFS) - Accumulated Gross Unrealized Loss shows an upward trend with a 47.6% CAGR.
debt_securities_trading_afs_gross_unrealized_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.00M | $183.00M | $265.00M | $160.00M | $422.00M | $580.00M | $53.00M | $221.00M | $135.00M | $176.00M | $16.00M | $78.00M | $7.00M | $3.00M | $129.00M | $36.00M | $1.00M | $24.00M | $35.00M | $2.00M |
| QoQ Change | — | +408.3% | +44.8% | -39.6% | +163.8% | +37.4% | -90.9% | +317.0% | -38.9% | +30.4% | -90.9% | +387.5% | -91.0% | -57.1% | >999% | -72.1% | -97.2% | >999% | +45.8% | -94.3% |
| YoY Change | — | — | — | — | >999% | +216.9% | -80.0% | +38.1% | -68.0% | -69.7% | -69.8% | -64.7% | -94.8% | -98.3% | +706.3% | -53.8% | -85.7% | +700.0% | -72.9% | -94.4% |